Table 2. Scores on experienced continuity and health and service outcomes stratified by phase of cancer treatment at recruitment.

				Treatment phase
	All (N=199)			Phase 1 diagnosis (N=46)			Phase 2 completion first treatment (N=46)			Phase 3 In remission (N=47)			Phase 4 On relapse (N=26)			Phase 5 Specialist palliative care (N=34)
	N	Mean	s.d.	N	Mean	s.d.	N	Mean	s.d.	N	Mean	s.d.	N	Mean	s.d.	N	Mean	s.d.	P-value
Continuity of care
Total score on 18 statements (range: 0–72)	181	51.8	9.9	45	52.1	9.3	41	50.8	12.9	41	52.1	7.9	24	53.2	6.1	30	51.0	11.4	0.879
Satisfaction
Satisfaction (range: 0–50)	191	41.7	8.8	42	41.5	8.8	46	39.3	9.9	46	44.0	6.3	26	43.6	6.8	31	40.8	10.8	0.086
SCNS
SCNS Physical and daily living needs (range 0–100)	194	11.7	4.7	44	12.0	4.4	45	11.6	4.4	46	9.4	4.1	27	12.7	5.2	33	13.4	4.6	0.001
SCNS Psychological needs (range 0–100)	186	21.4	8.8	44	21.3	9.5	44	22.8	7.9	45	18.6	7.9	25	25.0	10.7	28	20.6	7.2	0.037
SCNS Patient care+support needs (range 0–100)	193	11.6	3.7	44	12.8	4.3	46	12.2	4.2	47	9.9	2.7	26	11.7	3.3	30	11.6	2.9	0.003
SCNS Health system +information needs (range 0–100)	184	21.8	6.9	42	23.8	8.2	46	24.5	8.4	47	19.1	4.9	25	21.9	3.7	24	19.5	4.6	<0.001
SCNS Sexuality needs (range 0–100)	193	4.3	2.4	44	4.7	2.3	45	4.0	2.0	47	4.3	3.1	25	4.3	3.1	32	4.2	2.2	0.727
Euroqol
Euroqol ED5D (range: −0.59–1.00)	196	0.67	0.5	46	0.73	0.23	46	0.73	0.23	47	0.78	0.13	26	0.64	0.28	31	0.36	1.1	0.001
Euroqol thermometer (range 0–100)	190	66.6	18.9	43	64.3	20.7	45	69.5	16.4	45	74.8	15.8	26	60.8	20.3	31	58.7	18.1	0.001
GHQ
GHQ Total (range 0–28)	173	6.3	0.4	43	7.2	0.8	39	6.9	0.9	43	4.1	0.8	20	8.5	1.5	28	5.7	0.9	0.01
GHQ casenessa
Non case	92 (53.2%)			16 (37.2%)			22 (56.4%)			31 (72.1%)			9 (45.0%)			14 (50%)			0.022
Case	81 (46.8)			27 (62.8%)			17 (43.6%)			12 (27.9%)			11 (55.0%)			14 (50%)

^aCaseness defined at a threshold of 5/6.